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Hepatitis E Virus Infection in Solid Organ 
Transplant Recipients, France 
Technical Appendix 
Methods 
Detection of Hepatitis E Virus (HEV) Antibodies 
Anti-HEV IgM/IgG were detected by enzyme-linked immunosorbent assay (Wantai, 
Beijing, China). 
Plasma HEV RNA Concentrations 
HEV RNA in donor blood was detected and quantified by using a validated real-time 
PCR protocol with a detection limit of 100 copies/mL (i.e., 60 IU/mL) (1). 
HEV Genotype Determination 
HEV was genotyped by sequencing a 348-nt fragment within the open reading frame 
(ORF) 2 gene (2). The sequences were compared with reference HEV sequences (3). A 
confirmed case of transfusion-transmitted HEV infection requires evidence of infection in the 
recipient and a component of the blood from the donor testing positive for HEV RNA. It also 
requires that the nucleotide sequences of the 2 isolates be identical. 
 
Technical Appendix Table 1. Characteristics of the 7 transplant recipients potentially infected with HEV through blood transfusion, 
France 
Recipient Sex 
Organ 
transplanted 
Age at 
ALT 
elevation 
HEV antibody titer 
before transfusion,* 
U/mL 
 
Interval between event and 
ALT elevation, mo 
HEV RNA 
concentration at 
ALT elevation, 
log copies/mL Genotype IgG IgM Transfusion Transplantation 
R1 F Liver 34 – –  4 3 5.9 3 
R2 M Kidney 41 – –  1 42 3.6 3f 
R3 F Liver 42 – –  4 4 6.6 3f 
R4 F Liver 57 +, 0.25 –  4 4 5.4 3f 
R5 F Kidney 65 – –  4 4 4.1 3f 
R6 M Heart 44 – –  5 7 6.8 3f 
R7 F Liver 55 +, 10.97 –  0.2 82 5.1 3c 
ALT, alanine aminotransferase; HEV, hepatitis E virus. 
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Technical Appendix Table 2. Characteristics of the 7 blood donors with HEV RNA–positive, archived blood samples, France 
Donor/ 
recipient 
HEV RNA 
concentration, 
log copies/mL 
Geno
type 
Anti-HEV IgG 
titer, U/mL Anti-HEV IgM  
HEV-positive blood 
component  
Estimated 
transmitted 
volume, mL 
Transfused dose of 
HEV RNA, log 
copies 
D1/R1 4.7 3 + + Red blood cell unit 10 5.7 
D2.1/R2 2.8 3c – – Red blood cell unit 10 3.8 
D2.2/R2 3.3 3f +, 0.37 + Pooled platelet 
concentrate 
67 5.1 
D2.3/R2 6.6 3f not determined not determined Pooled platelet 
concentrate 
63 8.4 
D3.1/R3 4.3 3f – – Amotosalen-treated 
plasma 
209 6.6 
D3.2/R3 3.0 Na +, 2.97 + Pooled platelet 
concentrate 
69 4.8 
D3.3/R3 2.6 Na – – Pooled platelet 
concentrate 
67 4.4 
HEV, hepatitis E virus; Na, not available due to low HEV RNA concentration. 
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